Literature DB >> 32495943

Electrophysiological significance of the interatrial conduction including cavo-tricuspid isthmus during atrial fibrillation.

Byounghyun Lim1, Je-Wook Park1, Minki Hwang2, Ah-Jin Ryu2, In Soo Kim1, Hee Tae Yu1, Boyoung Joung1, Eun Bo Shim2, Hui-Nam Pak1.   

Abstract

KEY POINTS: The interatrial conduction, including Bachmann's bundle, the posterior septal conduction, the anterior septal conduction, and the cavo-tricuspid isthmus, contributes to the maintenance mechanisms of atrial fibrillation in a 3D biatrial model. The interatrial conduction ablation including a cavo-tricuspid isthmus ablation significantly affects the wave dynamics of atrial fibrillation (AF) and facilitates the AF termination or atrial tachycardia conversion of the AF after the circumferential pulmonary vein isolation. Additional cavo-tricuspid isthmus ablation after the circumferential pulmonary vein isolation improves long-term rhythm outcome after clinical AF catheter ablation. ABSTRACT: Although it is known that atrial fibrillation (AF) is mainly a left atrial (LA) disease, the role of the right atrium (RA) and interatrial conduction (IAC), including the cavo-tricuspid isthmus (CTI), has not been clearly defined. We tested AF wave dynamics with or without IAC in computational modelling and the rhythm outcome of AF catheter ablation (AFCA) including CTI ablation in clinical cohort data. We evaluated the dominant frequency (DF) in 3D biatrial AF simulations integrated with 3D-computed tomograms obtained from 10 patients. The IAC was implemented at Bachmann's bundle, posterior septum and the CTI. After virtual circumferential PV isolation (CPVI), we disconnected IACs one by one, and observed the wave dynamics. We compared the long-term rhythm outcome after CPVI alone and additional CTI ablation in 846 patients with AFCA. LA-DF was higher than RA-DF in AF (P < 0.001). After CPVI, the DF decreased significantly by additional IAC ablation (P = 0.003), especially in the LA (P = 0.016). The amount of DF reduction (P = 0.020) and rates of AF termination (P < 0.001) or AT conversion (P = 0.021) were significantly higher after IAC ablations including CTI than those without. In clinical AFCA, the AF recurrence rate was significantly lower in patients with additional CTI ablation than CPVI alone during 25 ± 20 months' follow-up (hazard ratio 0.60 [0.46-0.79], P < 0.001, Log rank P < 0.001). IAC contributes to the maintenance mechanism of AF, and IAC including CTI ablation affects AF wave dynamics, facilitating AF termination in 3D biatrial modelling. Additional CTI ablation after CPVI improves the long-term rhythm outcome in clinical AFCA, potentially in a paroxysmal type with accompanying atrial flutter, or atrial dimension close to normal.
© 2020 The Authors. The Journal of Physiology © 2020 The Physiological Society.

Entities:  

Keywords:  atrial fibrillation; cavo-tricuspid isthmus; computational modelling; interatrial conduction

Mesh:

Year:  2020        PMID: 32495943     DOI: 10.1113/JP279660

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  9 in total

Review 1.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

2.  Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.

Authors:  Inseok Hwang; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

3.  Pitfalls and potential for the use of computational modelling to guide the treatment of atrial fibrillation.

Authors:  David R Van Wagoner
Journal:  J Physiol       Date:  2020-07-15       Impact factor: 6.228

4.  Anti-atrial Fibrillation Effects of Pulmonary Vein Isolation With or Without Ablation Gaps: A Computational Modeling Study.

Authors:  Ze Jin; Inseok Hwang; Byounghyun Lim; Oh-Seok Kwon; Je-Wook Park; Hee-Tae Yu; Tae-Hoon Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

5.  Ablation and antiarrhythmic drug effects on PITX2 +/- deficient atrial fibrillation: A computational modeling study.

Authors:  Ze Jin; Inseok Hwang; Byounghyun Lim; Oh-Seok Kwon; Je-Wook Park; Hee-Tae Yu; Tae-Hoon Kim; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Cardiovasc Med       Date:  2022-07-19

6.  Ablation index-guided ablation with milder targets for atrial fibrillation: Comparison between high power and low power ablation.

Authors:  Zheng Liu; Li-Feng Liu; Xiao-Qin Liu; Jiapeng Liu; Yu-Xin Wang; Ye Liu; Xing-Peng Liu; Xin-Chun Yang; Mu-Lei Chen
Journal:  Front Cardiovasc Med       Date:  2022-08-04

7.  Paroxysmal atrial fibrillation originating from the cavotricuspid isthmus: Utility of self-reference mapping with a high-density grid mapping catheter for identification of non-pulmonary vein triggers.

Authors:  Koji Sudo; Yuichiro Sagawa; Atsuhito Oda; Hirofumi Arai; Takatoshi Shigeta; Yasuteru Yamauchi
Journal:  HeartRhythm Case Rep       Date:  2022-05-26

8.  Role of interatrial conduction in atrial fibrillation: Mechanistic insights from renewal theory-based fibrillatory dynamic analysis.

Authors:  Jing Xian Quah; Evan Jenkins; Dhani Dharmaprani; Kathryn Tiver; Corey Smith; Teresa Hecker; Majo X Joseph; Joseph B Selvanayagam; Matthew Tung; Tony Stanton; Waheed Ahmad; Nik Stoyanov; Anandaroop Lahiri; Fahd Chahadi; Cameron Singleton; Anand Ganesan
Journal:  Heart Rhythm O2       Date:  2022-05-16

9.  Clinical Outcomes of Computational Virtual Mapping-Guided Catheter Ablation in Patients With Persistent Atrial Fibrillation: A Multicenter Prospective Randomized Clinical Trial.

Authors:  Yong-Soo Baek; Oh-Seok Kwon; Byounghyun Lim; Song-Yi Yang; Je-Wook Park; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Dae-Hyeok Kim; Moon-Hyoung Lee; Junbeom Park; Hui-Nam Pak
Journal:  Front Cardiovasc Med       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.